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Abstract  
Epidemiological evidence linking obesity with increased risk of cancer is steadily growing, although 
the causative aspects underpinning this association are only partially understood. Obesity leads to a 
physiological imbalance in the regulation of adipose tissue and its normal functioning, resulting in 
hyperglycaemia, dyslipidaemia and inflammation. These states promote the generation of oxidative 
stress, which is exacerbated in obesity by a decline in anti-oxidant defence systems. Oxidative stress 
can have a marked impact on DNA, producing mutagenic lesions that could prove carcinogenic. 
Here we review the current evidence for genomic instability, sustained DNA damage and accelerated 
genome ageing in obesity. We explore the notion of genotoxicity, ensuing from systemic oxidative 
stress, as a key oncogenic factor in obesity. Finally, we advocate for early, pre-malignant assessment 
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1. Connecting obesity and cancer via oxidative stress and DNA damage 
The association of obesity with cancer is naturally one of the most concerning aspects and the object 
of intense scrutiny. A number of prospective and case-control studies have recognised an 
epidemiological correlation between obesity and cancer in a sex and site-specific manner. Published 
evidence has been extensively reviewed [1, 2]. A recent paper by Kyrgiou and colleagues [3], in 
which over two-hundred meta-analyses of observational studies linking adiposity to cancer risk were 
systematically evaluated, has confirmed definitive evidential association between obesity and eleven 
types of cancer, including oesophageal adenocarcinoma, multiple myeloma, and cancers of the 
gastric cardia, colon, rectum, biliary tract system, pancreas, breast, endometrium, ovary and kidney.  
Obesity manifests with inflammation, hyperglycaemia and dyslipidaemia, maintained to be drivers of 
carcinogenesis as they may endorse the biological mechanisms associated with tumour development, 
sustainability and metastasis [4]. These pathological states in obesity may be have a key role in the 
initiation of cancer as chronic inflammation and the metabolic disturbances in obesity have a 
common pathological consequence termed oxidative stress, a long-recognised threat for genome 
stability and integrity [5]. Cellular function, viability and fate are predominantly determined by the 
genomic stability and integrity of the cell. Conversely, cancer genomes are highly rearranged and 
genomic instability has been described as an enabling characteristic of cancer [6]. Oxidative stress 
has a physiological relevance as the excessive generation of reactive oxygen species (ROS) may lead 
to oxidative DNA damage and induce tumorigenic alterations [7], as well as drive genomic 
instability by mimicking replication stress [8]. 
ROS are produced via many fundamental cellular processes. Endogenous sources of ROS include 












stimulated by growth factors and serve as necessary signalling molecules [9] . Concentrations of 
ROS are tightly regulated under a redox (reduction oxidation) system to prevent toxicity. Obesity is 
known to disrupt the redox system by elevating the production of ROS, and decreasing the 
availability of anti-oxidant defence enzymes [10]. A calorie-rich diet and an abundance of 
macronutrients in obesity, calls for continuity in the Krebs cycle that consequently leads to a leak of 
more electrons from the mitochondrial electron transport chain.  These electrons promote a reduction 
of oxygen molecules – a process that will generate more ROS. However, the over-generation of ROS 
in obese individuals is brought about by more than just a continuum in the Krebs cycle.  
 
2. The oxidative burden of inflammation 
Chronic inflammation is a well-known etiological factor for DNA damage and promotor of 
neoplastic transformations in cells [11]. In a state of obesity, the release of pro-inflammatory 
molecules including CRP, TNF-alpha and IL-8 from adipose tissue is well documented [12–15]. 
Adipocytokines particularly TNF-alpha, IL-6 and IL-1 promote the recruitment of various cells 
including neutrophils, macrophages and dendritic cells, indicating the beginning of an inflammatory 
process [16]. These cells not only generate more pro-inflammatory cytokines but also encourage 
production of ROS/RNS via NADPH oxidases, particularly the NOX1, NOX2 and NOX4 isoforms 
[17]. Further production of ROS/RNS is generated as obesity develops with hypertrophy and 
hyperplasia of adipocytes, resulting in tissue hypoxia and cell necrosis [10]. 
Cell necrosis causes altered adipokine expression, including reduced levels of the anti-inflammatory 
hormone adiponectin [18]. Adiponectin is secreted by adipose tissue and may inhibit the actions of 
TNF-alpha and prevent recruitment of inflammatory cells [19].  Adiponectin deficiency may play a 
pathological role further than inflammation as it has been associated with obesity and cancers of the 












Increased death of adipose cells has also been indicated as a path to release cell-free DNA into 
systemic circulation [25]. Nishimoto and collaborators [26] have recently identified that release of 
cell –free DNA caused by adipocytes’ degeneration promotes macrophages accumulation in adipose 
tissue via Toll-like Receptor 9 (TLR9), originally known as a sensor of exogenous DNA fragments. 
Macrophage infiltration into adipose tissue is characteristic of obesity and may have further 
pathological consequences when they secrete high concentrations of nitrous oxide (NO) [27]. In high 
concentration, NO can cause deamination, oxidation and strand breakages in DNA [28].  
Chronic inflammation and its ability to inflict DNA damage has been demonstrated in models of 
H.pylori associated gastrointestinal cancer [29] and ulcerative colitis associated colon cancer [30], as 
well as HCV mediated liver cancer [31]. Unresolved inflammation has also been reported to cause 
pre-malignant lesions in the mouth [32]. Izano and colleagues [33] investigated the risk of increased 
IL-6, CRP and TNF-alpha with colon cancer and other obesity related cancers in a follow-up study 
of 2490 participants. Their findings evoke the causative relationship between chronic inflammation 
and colon cancer in obese adults, but evidence for other obesity related cancers is non-conclusive. 
Overall, there is substantial evidence that chronic inflammation is a causative factor for DNA 
damage. This phenomenon should be further explored in obesity to elucidate the risks of 
carcinogenesis. 
3. Dyslipidaemia and Lipid Peroxidation  
Obesity coincides with an increased circulation of free fatty acids (FFA) and the deposition of excess 
fat in white adipose tissue (WAT), marked as dyslipidaemia [34]. Excessive plasma lipids are 
susceptible to oxidative modification which generates more ROS, and can also activate a protein 
kinase C pathway resulting in elevated production of nitroxide – a potent ROS [35]. The deposition 













Dyslipidemia - mainly the elevation in low density lipoproteins and fall in high-density lipoproteins, 
disrupts the redox system and leads to lipid peroxidation in obesity [36]. Lipid peroxidation is a 
mechanism for generating malondialdehyde (MDA) that can react with DNA to produce mutagenic 
MDA-DNA adducts such as MDA-deoxyguanosine [36]. MDA has the potential to cause inter-
strand cross links with DNA [37] and point mutations [38]. The first reaction can be highly 
cytotoxic, whereas the latter could prove carcinogenic [39]. Elevated levels of MDA have been 
identified in both adult [40] and child [41] models of obesity. As MDA levels can also be a 
remarkable finding in breast and lung cancer patients [42], a potential causative association between 
lipid peroxidation, DNA damage and cancer risk in obesity can be argued.   
4. Hyperglycaemia and ROS generation 
In obese individuals, insulin signalling can be significantly impaired. Glucose transport, protein C 
kinase and other enzymatic activity can be defective, resulting in increased plasma glucose levels 
(hyperglycaemia) [43]. FFA circulation and uptake in the liver can further contribute towards 
hyperglycaemia when FFA is selected as an energy source over glucose [44]. Hyperglycaemia has 
been associated with increasing ROS generation four-fold in adipocytes and thus promoting 
inflammation [45]. These factors also contribute towards hyperinsulinemia and insulin resistance in 
obesity [46]. Hyperinsulinemia correlates with decreased levels of IGF binding protein 1 and IGF 
binding protein 2, thereby readily causing an increase in the availability of IGF-1 [46]. 
Excess free circulating IGF-1 has been associated with an increased risk of breast cancer [47] and 
colorectal cancer [48]. Although, IGF-1 was found to have a role in activating DNA repair pathways 
against oxidative DNA damage [49], elevated levels of IGF-1 in obesity may be a physiological 
response to oxidative stress [50] but this avenue is open to question.  
Moreover, IGF-1 has been linked with down-regulation of sex hormone binding globulin (SHBG) 
[51], which could result in an increase in the availability of free oestrogen [52]. The association 












levels in obese individuals [53,54]. Traditionally, sustained exposure to oestrogen has been 
associated with upregulation of genes that control cell proliferation and cell cycle progression, 
marking an important role in tumorigenesis [55]. In addition, oestrogen may endogenously induce 
DNA modifications, create oestrogen-DNA adducts and generate oxidative DNA damage [56]. 
Oxygen radicals can also be generated as a result of the redox cycling of oestrogen metabolites [56]. 
Therefore, it can be inferred that hyperglycaemia in obese subjects may promote ROS generation via 
IGF-1, insulin and oestrogen, thus increasing the likelihood of DNA damage and cancer initiation.  
5. Inadequate Anti-oxidant Defence  
Increased BMI has been associated with a decline over time in essential regulators of the redox 
system. Ozata and collaborators [57] identified decreased activity of SOD and GPx in erythrocytes of 
76 male obese subjects, in relation to age-matched healthy weight controls. Similarly, recent 
investigations have confirmed lower activities of SOD and GPx in obese women, although no 
significant difference in CAT activity was observed [58]. Interestingly, Erdeve and collaborators [59] 
reported the SOD enzyme to be increasingly active in a cohort of obese children. However, this 
finding was in parallel to identification of increased ROS production in the same cohort, suggesting 
that obesity may trigger an early physiological response to oxidative stress in children by increasing 
the activity of anti-oxidant enzymes to scavenge the ROS. Similarly, total oxidant status (TOS) and 
total anti-oxidant status (TAS) were both reported to be higher in a cohort of 37 obese children 
compared to health weight controls [60]. Other findings suggest that the implications of oxidative 
stress worsen with the severity of obesity, placing obese children at higher risk of oxidative stress. 
Albuali and colleagues [61] identified elevated activity of SOD and CAT in overweight children but 
found that this level of functioning did not exist in the obese cohort. Anti-oxidant status in obesity 
appears to be an interesting paradox whereby anti-oxidant defence mechanisms may be maximised in 












preventing pathological consequences is unknown. Overall, there are substantial indications of a 
weakened anti-oxidant defence mechanism in both adult and childhood obesity [57,58,63].  
A decrease in anti-oxidant activity has been linked with DNA damage and acute lymphoblastic 
leukaemia in children, although it is complicated to establish whether this association is causative 
[64]. A study conducted on mice deficient in SOD activity presented them to have a decreased 
lifespan and increased likelihood of liver malignancies, [65]. A latter review by Asaduzzaman and 
colleagues [66] explored the paradoxical roles of anti-oxidant enzymes in carcinogenesis. They 
highlighted that CAT, SOD and GPx activity is heterogeneous in a variety of cancers. Recent studies 
in oral [67] and breast cancer [68] have given a deeper insight into these roles and suggest that 
elevated activity of some of these enzymes may also be a cause for concern. Overall, it is plausible 
that inadequate anti-oxidant mechanisms may predispose to malignancy, possibly via increased DNA 
damage.  
It is important to consider that obesity often coincides with a nutrient-poor diet and a lack of dietary 
intake of anti-oxidants [69]. Low levels of particular plasma micronutrients, including folate, vitamin 
B, vitamin C, iron and zinc, may imitate the effects of radiation on DNA, potentially resulting in 
DNA strand breaks or the production of oxidative lesions [70]. It has also recently emerged that 
obesity may cause vitamin D deficiency [71]. Vitamin D may play a significant role in managing the 
redox system, as it was found to upregulate the anti-oxidant enzyme G6PD in human prostate 
epithelial cells [72] and is associated with reducing the incidence of prostate cancer [73]. Thus, low 
levels of anti-oxidant enzymes in obesity may also be attributed to micro-nutritional deficiencies. 
Collectively these disturbances in the redox system and antioxidant defences may increase the 
potential for DNA damage and risk of cancer, although further research is required to confirm any 
causative association.  
6. Markers of DNA damage in obesity 












Micronuclei (MNi) are well-recognised markers of genotoxic stress and genomic instability. By 
definition, a micronucleus is an extra-nuclear body within the cell cytoplasm containing 
chromosomal fragments or whole chromosomes, resulting either form clastogenic events, such as 
DNA double strand breaks (DSBs), or aneugenic events, such as segregation defects giving rise to 
abnormal numbers of chromosomes. There are indications that retention of micronuclei containing 
whole chromosomes can proceed into several cell generations [74]. Recently, the relevance of 
micronuclei as potential drivers of malignant transformation has come to the fore in relation to the 
phenomenon of chromothripsis, a newly described mutational process whereby micronuclei division 
cycles enable accumulation of mutagenic re-arrangements in a single or few chromosomes [75]. 
These localized chromosomal re-arrangements may be transferred to daughter nuclei in subsequent 
mitotic cycles and play a role in generating a pre-cancerous genome. Micronuclei may display a lack 
of nuclear membrane integrity when occurring in normal or cancer cells. Therefore, the nuclear 
envelope of a micronucleus is more likely to rupture, causing exposure of self-DNA to the cytosol. 
Possible immuno-stimulatory consequences of this event have recently been reported in a mouse 
model and human cancer cells [76].  
Evidence for micronuclei frequency as a possible predictor of cancer is being explored. A series of 
observational and follow-up studies have consistently demonstrated raised incidence of micronuclei 
in 10 different types of cancer (examples in Table 1.). Most relevantly, prospective research 
approaches have associated an elevated frequency of micronuclei with an increased risk of 
developing cancer. Early research by Bonassi and colleagues followed up 6718 participants across 20 
sites after their participation in the Human Micronucleus (HUMN) project and reported a statistically 
significant risk of stomach and urogenital cancer to be associated with a high baseline frequency of 
micronuclei in lymphocytes [77]. Another longitudinal study reported evidence to support a possible 












for up to 14 years. Retrospective analysis indicates that participants that developed cancer had, on 
average, a three-fold increase in micronucleus frequency at baseline [78].  
Ageing appears to be a major contributing factor to chromosomal instability and micronuclei 
formation. The influence of age on micronuclei frequency has been quite extensively researched. In 
an initial study on a large population of 791 participants, micronuclei frequency was found to 
increase with age and was higher in women than men [79]. Subsequent investigations have detected 
a biphasic relationship between age and induction of micronuclei in lymphocytes, with a positive 
correlation between micronuclei and age up to 50 years, but an inverted association beyond that age 
threshold [80,81]. This biphasic response may owe to the decreased proliferative capacity of cells in 
older individuals, that may exist as a mechanism to limit possible genomic instabilities [81]. 
Moreover, the frequency of micronuclei was reported as at least three times higher in the buccal 
mucosa of adults aged over 60, compared to cells from a cohort of 19-29 year olds [82]. More recent 
research draws out that micronuclei frequency in lymphocytes can be an indicator of frailty in an 
ageing cohort, however, whether micronuclei frequency in buccal epithelial cells is positively 
associated with age is yet to be confirmed [83] .  
There is increasing evidence to suggest a link between adiposity and micronuclei frequency (Table 
2.). The first indication of a positive correlation between micronuclei frequency and BMI was 
provided by a research on polycystic ovarian syndrome (PCOS) [84]. Further evidence was provided 
by Andreassi et al., [85], highlighting the correlations between BMI, DNA damage and insulin 
resistance in women with PCOS. Later, BMI was related with an almost four-fold increase in 
micronuclei frequency within the PBLs of 83 obese adults, when compared with normal-BMI 
controls [86]. A positive correlation between BMI and the number of apoptotic and necrotic cells in 
plasma was identified suggesting the elevated frequency of dying cells to be a result of them 
possessing a damaged and unstable genomic state. Furthermore, an increased association between 












first study in which the occurrence of genome damage has been investigated in childhood obesity. 
Compelling evidence on positive associations between weight and length at birth, and three markers 
of chromosomal instability (MN frequency, nucleoplasmic bridges and nuclear buds) has been 
reported [88].  
Some studies in human and animal models have highlighted discrepancies in terms of influence of 
adiposity on micronuclei frequency. Although MN frequency was positively associated with age in 
300 Korean adults, no correlations were drawn with BMI [89]. An in-depth meta-analysis by Croco 
and collaborators [90] discovered body mass to be a determining factor for genomic stability, 
demonstrated by erythrocyte micronucleus frequencies across 47 mammalian species. However, 
more recently a, research on a diet-induced mouse model of obesity did not find a significant 
difference in the levels of micronuclei in erythrocytes or reticulocytes, albeit the obese mice 
sustained a greater frequency of Pig-a mutant erythrocytes, a newly described biomarker for somatic 
mutations [91]. 
The origins of micronuclei formation in obesity need to be extensively researched. Although, chronic 
inflammation is a possible pathological factor that may underpin the pathway to micronuclei 
formation, as identified in patients with cirrhotic liver as a result of hepatitis C infection [92]. 
Whether this concept can be applied to low-grade, systemic inflammation identified in obesity is an 
important, unanswered question.  
6.2  8-OH-2-deoxy Guanosine (8-OHdG) 
8-oxo-deoxy-guanosine (8-OHdG) is the product of free-radical induced oxidation of guanosine. 8-
OHdG can be detected in serum, saliva and urine, making it an ideal DNA damage biomarker for 
large population based studies. The possible mutational consequences of this lesion, including mis-
pairing with adenosine, inhibiting methylation of adjacent cytosines and deleterious GàT 
transversion mutations have been recently reviewed [93]. Ramon and colleagues [94] first identified 












regions, by demonstrating that 8-OHdG alters binding of the transcription factor Sp1. The role of 
Sp1 transcription factors in cell growth, development, and death have been extensively reviewed 
concluding Sp1 as key players in carcinogenesis [95]. In addition, a recent review highlighted that  
8-Oxoguanine DNA Glycosylase 1 (OGG1) – a key repair enzyme, may also play a role in 
carcinogenesis by recruiting 8-OHdG as a ligand for gene regulation and activation of the Ras 
pathway [96].  
The clinical significance of 8-OHdG has been extensively discussed by Cooke and colleagues, 
bringing to light that 8-OHdG is a well-established risk marker for age-related pathologies such as 
cancer [97]. The GT to AC substitution is a commonly described mutation that is derived from the 
oxidation of guanosine and is also prominent in gastrointestinal tumours [98]. It is not surprising that 
elevated serum or urinary 8-OHdG lesions are undisputedly associated with malignant tumours at 
multiple sites (Table 3.).  
Interestingly, levels of 8-OHdG are also significantly higher in patients with pre-cancerous lesions of 
buccal mucosa [99] and dysplastic cervical cells [100]. Therefore, there may be a potential for 8-
OHdG to be utilised as a clinical risk marker to detect early carcinogenic processes.  
For long, the phenomenon of ageing has been described as a process that incorporates free-radical 
mediated attacks on nuclear DNA, leading to oxidative stress, telomere attrition and a halt in cell 
division and proliferation [101]. 8-OHdG lesions may have implications in cellular senescence and 
ageing caused by oxidative stress. This is because early research recognised 8-OHdG to emerge from 
senescing human fibroblasts in higher concentrations than their younger counterparts [102]. More 
recent studies have recognized increasing concentrations of 8-OHdG to be associated with age-
related cataracts [103], Alzheimer’s [104], Parkinson’s [105], and vascular complications in type 2 
diabetes [106]. This suggests that 8-OHdG is a specific biomarker for oxidative stress that is 












Multiple studies have assessed the correlation of 8-OHdG with adiposity with emerging findings not 
devoid of discrepancies (Table 4.). de la Maza and colleagues were the first to report an association 
between increased body fat and oxidative DNA damage by assessing 8-OHdG in skeletal muscle 
[107]. These associations were based upon self-reported weight gain over the last 10 years by 
patients undergoing a hernia operation. It is intriguing that increased 8-OHdG in these weight gainers 
coincided with increased TNF-alpha – an undisputed marker of inflammation. Another study 
assessed 8-OHdG concentrations in lymphocytes and was unable to identify a correlation with BMI 
in adults [108].  In contrast, there are findings that indicate a correlation between leanness and 
increased oxidative stress. A one-point reduction in BMI was reported to coincide with a 2.7% 
increase in urinary 8-OHdG [109].  Similarly, Donmez-Altuntas and collaborators reported 
decreased levels of 8-OHdG in plasma of obese adults compared to adults of healthy weight, 
although other biomarkers of DNA damage including micronuclei frequency was elevated [86]. 
More recently, a study conducted in over 100 obese and healthy weight men concluded that there 
were no significant differences in urinary 8-OHdG [110]. In summary, the evidence for 8-OHdG as a 
marker of oxidative stress in adult obesity is inconclusive, this outcome likely due to discrepancies 
arising from differences in the degree of obesity in participants between studies.  
Similarly, discordant are the results of investigations carried out across adolescent cohorts. The first 
evidence showing a positive association between BMI and oxidative DNA damage in obese 
adolescents, quantified 8-OHdG in serum via an ELISA method [111]. Across 103 adolescents, a 
BMI greater than the 95th percentile was associated with increased 8-OHdG. However, Protano and 
collaborators assessed 8-OHdG in urine across 159 children via liquid chromatography–tandem mass 
spectrometry and found an inverse association [112]. Yet more recent research has reported a higher 
concentration of 8-OHdG in urine from a much smaller cohort - 24 obese children [113]. However, 
the children in this cohort also presented with insulin resistance and metabolic syndrome (MS). The 












oxidative DNA damage, as MS has been suggested to disrupt anti-oxidant defences and encourage 
oxidative stress [114].  
6.3  -H2AX foci 
Induction of nuclear -H2AX foci or gamma foci signal the start of a crucial repair process that 
follows a potentially carcinogenic DNA lesion [115]. DNA double strand breaks (DSBs) are detected 
by the MRN repair complex consisting of NBS1, MRE11 and Rad50. This recognition process leads 
to activation and recruitment of ATM and a subsequent phosphorylation of -H2AX and other targets 
including BRCA1. As reviewed by Khanna & Jackson, DSBs can have lethal consequences for a cell 
as they can drive the cell into apoptosis or towards carcinogenesis [116].  Although the suitability of 
-H2AX as a DNA damage marker has been questioned as its presence has been observed in the 
absence of recognisable DNA damage [117], evidence against the use of -H2AX as a marker of 
DSBs remains limited. Recent research indicates the induction of -H2AX to coincide with 
unrepaired DSBs as well as blocked replication forks [118,119]. Indeed, the suitability of gamma 
foci continues to be explored as a diagnostic and prognostic marker for cancer (Table 5).  
A higher frequency of -H2AX foci have been found expressed in breast cancer cells from the more 
aggressive triple negative breast cancer (TNBC) when compared to cells from non-TNBC [120].  
Gamma foci have also been suggested as an appropriate diagnostic and prognostic marker for colon 
cancer [121] and more recently, epithelial ovarian cancer [122]. The detection of -H2AX in pre-
cancerous lesions of the bladder in vivo [121] and pre-cancerous lesions of the lung and skin in vitro 
gives reason to explore the use of -H2AX as a possible predictor of cancer [123].  
The DNA damage response to DSBs has been described as a major pathway to cellular senescence in 
mouse models [124,125]. Sedelnikova and collaborators discovered -H2AX foci at sites of 
persistent DSBs that led to cellular senescence in ageing mice and human cell lines, indicating that y-











tested this association in cell lines from patients with Werner syndrome – a disorder characterised 
with premature ageing, and identified a comparable association, although recruitment of DNA 
proteins was slower to -H2AX foci. A more recent study also documented a linear correlation 
between -H2AX foci and ageing in human cell lines [126]. Schurman and colleagues further studied 
the association of -H2AX foci with age related disorders and found a positive correlation with 
cataracts and hypertension, but not with cancer [126]. This indicates the need for further research 
identifying whether there is a causative role for -H2AX foci in ageing and cancer. 
Redon and colleagues reviewed the practical applications of H2AX foci in population studies, and 
identified their extensive use to draw associations between chronic inflammation and DNA damage 
[127]. It was emphasised that the long-term consequences of identifying elevated -H2AX foci 
remains an open avenue.   
There is consistent evidence to suggest -H2AX foci are elevated with adiposity (Table 6). 
Villaret and colleagues reported premature senescence of visceral adipose tissue cells in obese 
subjects, and found the endothelial cells within to be marked with a state of inflammation and up-
regulated hypoxia genes in coexistence with increased -H2AX foci [128]. Interestingly, this 
phenomenon was not documented in sub-cutaneous adipose tissue to the same extent. In addition, for 
the first time, -H2AX foci were documented as 8x fold higher in cultured PBLs of obese children 
when compared to healthy weight controls in a study led by Scarpato and collaborators [87]. They 
also assessed chromosomal aberrations, via the micronucleus assay, in a large cohort of obese 
children, alongside markers of chronic inflammation and attributed an increased rate of DSBs to 
overweightness. The confounding, observed increase in TNF-a, CRP and IL-6 manifests a causative 
link between chronic low-grade inflammation and DNA damage in obese children. In 2016, the same 
investigators deepened their investigations into the repair efficiency of DSBs between obese and 
normal weight adolescents by measuring the response of PBLs to mitomycin C [129]. An almost 2 












healthy controls, measured by y-H2AX foci. Intriguingly, the level of DNA repair in the obese 
cohort was repaired faster and more efficiently than in the healthy weight counterparts. This research 
indicates that there may be a potential for DNA repair mechanisms to be able to cope with the 
emerging accounts of DNA damage in obesity, but warrants further investigations.  
Furthermore, the documented evidence for increased DSB repair initiation linked with childhood 
obesity has also been implied in obese Zucker rats - a model of genetically predisposed obesity 
[130]. Obese Zucker rats presented a greater expression of -H2AX foci in lung, pancreatic, 
oesophageal, kidney and gut tissues when compared to lean counterparts. It was also noted that older 
rats (9-13 weeks) had a more prominent increase in the expression of -H2AX foci than younger rats 
(3-4), further implying that DSB events may correlate with age. Nonetheless, it is important to 
comprehend that the induction of -H2AX in tissue is a well-regulated proper response to reversal of 
DNA Double strand breaks, although, the relationship between the number of foci present and 
number of DSBs repaired by -H2AX foci is questionable.  
6.4  Comet Tails 
Comet tails are sensitive biomarkers of deteriorating chromosomal integrity as they enable inference 
of chromosomal breakages. The comet assay (single cell gel electrophoresis) used to detect these 
tails is a well-established laboratory assay that was first pioneered by Ostling & Johanson in 1984 
[131]. Single cells are embedded in agarose and treated to remove nuclear membranes and histone 
material prior to electrophoresis. The application of a current allows broken, uncoiled DNA loops to 
migrate faster towards the anode, creating the shape of a comet, with intact DNA remaining in the 
comet head whilst damaged, ‘broken’ DNA migrates in the comet tail. Subsequently, the DNA is 
treated with an intercalating dye and visualised with fluorescence microscopy. The length of the tail 
and percentage of DNA inside the tail is a taken as a directly proportional measure of DNA damage 












chemotherapy, and is now evolving into a diagnostic marker of cancer [133]. Several cases of 
malignancy have been assessed via the comet assay and found to display significant DNA damage 
(Table 7.). Furthermore, Katarkar and colleagues identified two remarkable observations via a case-
control study using 260 participants. The first is the applicability of the comet assay in PBLs as a 
biomarker for pre-malignant lesions of the buccal mucosa [134]. Secondly, they uncovered that DNA 
damage in PBLs correlates with DNA damage in cells extracted from the buccal mucosa, as 
measured by the presence of micronuclei. This evidence leads to the conclusion that the comet assay 
in PBLs may possibly act as a cancer susceptibility biomarker for non-haematological malignancies. 
This avenue requires further exploration and warrants studies to investigate the relevance of non-
invasive assays; such as the buccal micronucleus assay, in susceptibility to systemic DNA damage 
and carcinogenesis.  
The comet assay has also been applied to evaluate DNA damage in ageing [135,136]. Research has 
suggested the comet assay may be a functional biomarker for pre-mature ageing, as increased DNA 
damage was observed in cells from patients with Hutchinson-Gilford progeria syndrome (HGPS) 
when compared to normally ageing human fibroblasts [136]. These investigations intensify the link 
between DNA damage and ageing, when explored using the comet assay.  
Body fat can be proposed as a pathological factor for chromosomal breaks following investigations 
with the comet assay in rat models of obesity and in humans (Table 8.) A correlation study first 
indicated a positive association between BMI in females and oxidative DNA damage via the comet 
assay [108]. Later, A positive correlation between increased chromosomal damage and BMI (>30 ) 
was demonstrated by the comet assay in pregnant women of a Pakistani population [137] and was 
subsequently confirmed in an Indian population too [138]. Remarkably, DNA damage was also 
identified via the comet assay in women with a normal BMI but elevated fat mass [139]. This 
‘normal-weight-obese’ cohort also had higher levels of oxidative DNA damage, measured by 8-












in obesity to consider measures of adiposity wider than BMI, as fat mass may have a stronger 
correlation with genomic instability. DNA damage has also been confirmed via the comet assay in 
liver cells of obese female Zucker rats [140]. This research identified age to be an important factor 
when interpreting results from the comet assay, since Zucker rats younger than 15 months showed no 
evidence of comet tails. Comet tails are indicative of DNA damage in adult and animal models of 
obesity. However, there is a lack of studies investigating the expression of comet tails in adolescent 
or childhood obesity.  
More recently, a nutritional intervention study outlined a decrease in DNA single strand breaks with 
weight reduction in 50 participants, even though the obese/overweight participants did not have high 
levels of DNA damage at baseline [141]. Intriguingly, DNA damage was associated with increased 
BMI and breast cancer risk in a case-control study [142]. However, in the cancer-free control cohort, 
BMI was inversely associated with DNA damage [142]. It has been suggested that this discrepancy 
could be an outcome of increased metabolic rate in lean individuals and a possible generation of 
more ROS. In the breast cancer cohort, the positive association between BMI and DNA damage 
could be a consequence of defective DNA repair and marked chromosomal instabilities that are 
consistently found in cancer. Furthermore, this study analysed BMI data for only 45 cancer free 
patients, indicating that these findings may lack statistical power. Nonetheless, the role of the comet 
assay as a biomarker for genomic instability in increasing adiposity is propitious.  
   6.5 Telomere Length  
Telomeres play a fundamental role in maintaining chromosomal integrity and can substantially 
underpin the genomic instabilities associated with carcinogenesis [143]. Telomeres are vital 
segments of non-coding DNA repeat sequences (TTAGGG) that are located at the ends of 
chromosomes and lose their DNA bases at every round of the cell cycle, consequently shortening in 
length. Telomere length can be assessed in multiple tissue types via a variety of techniques that 












gold standard - Terminal Restriction Fragmentation (TRF). Telomere shortening to a critical length 
should ultimately result in replicative senescence, hence the reason for telomeres long being linked 
to the phenomenon of cellular ageing [144,145]  
Telomere shortening has been discussed as a biomarker for detecting the onset of multiple age 
related disorders including cardiovascular disease and diabetes [146], Alzheimer’s [147], Parkinson’s 
[148] and arthritis [149]. Telomere length has also been assessed in disease models of accelerated 
ageing including Werner’s syndrome [150] and Hutchinson-Gilford Progeria (HGPS) [151]. It is of 
interest that despite telomere shortening being a phenomenon common to both disorders, patients 
with Werner’s syndrome have an increased susceptibility to acquiring cancer, whereas HGPS is 
associated with a resistance to oncogenic transformations [152]. To conclude, telomere shortening 
has become a well-known, undisputed biomarker for ageing, but its role as a biomarker for detecting 
early pathological changes in age-related disorders such as cancer, requires clarification.    
 Case-control studies in cancer patients have strengthened the associations between telomere 
attrition, genomic instability and possible increased risk of cancer (Table 9.). Interestingly, this 
phenomenon may be identified systemically in cancer patients, as Broberg and colleagues reported 
significantly shorter telomeres in buccal cells harvested from patients with bladder cancer, when 
compared to cancer free controls [153]. A recent comprehensive review of over 23,000 cases has 
brought to light that the significance of telomere length as a marker for cancer is more complex 
[154]. This research presented a heterogeneous relationship across different cancer types, including a 
statistically significant correlation between decreased telomere length and increased risk of GI tract, 
head and neck cancers, but not skin cancers. Contrastingly, it was also reported longer telomere 
length was more likely to increase the risk of skin cancer, indicating that telomeres may play a more 
diverse, tissue-specific role [154]. Similarly, other studies have noted a non-linear relationship for 
cancers of the breast [155], pancreas [156] and oesophagus [157]. In the case of lung cancer, both 












from these studies indicate that telomere length is an important marker of genomic instability where 
excessive shortening or lengthening may both be drivers or indicators of cancer development. 
Telomere attrition may promote generation of cancer stem cells by causing a series of chromosomal 
fusions, anaphase bridge formations and breakage-fusion-breakage cycles that enable DNA damage 
to accumulate [143]. Whereas lengthened telomeres may enable the cell to enter into more division 
cycles, thus increasing the susceptibility of the genome to abnormalities, lethal mutations as well as 
immortality. Increased telomere dysfunction has also been identified alongside chromothripsis in 
patients with increased susceptibility to developing cancer (sufferers of L-Fraumeni syndrome) [160] 
suggesting an additional role for telomere attrition in increased catastrophic DNA re-arrangements. 
However, there is a greater need for more case-control studies to confirm these speculations and to 
test the applicability of telomere length as a biomarker for tissue-specific cancer risk.  
Initial reports of telomere shortening in obesity were presented in a study conducted on 561 female 
twins and linked increased adiposity with a risk of up to 8.8 years of ageing [161]. Interestingly, a 
subsequent study published by Nordfjäll and colleagues confirmed these findings with a variety of 
obesity parameters including BMI, weight, and waist and hip circumference [162]. Although, the 
study reported a gender bias as these findings were only statistically significant in women. In 2009, 
an extensive study by Kim and collaborators also found an inverse correlation between weight gain 
and telomere length in 647 women [163]. Shorter telomere length has also been reported in cells of 
subcutaneous adipose tissue extracted from obese men and women [164]. A number of subsequent 
studies have built evidence to support the hypothesis that increased body fat in adults is an 
independent causative factor for accelerated ageing (Table 8). However, discrepancies in the 
evidence do exist, as some studies have found little or no association between multiple measures of 
adiposity and telomere dysfunction in women [165]. This highlights that telomere maintenance is a 
highly regulated and complex process affected by other physiological factors such as menstrual 












A study that established a link between obesity and telomere shortening in adults, was unable to 
verify this phenomenon in obese children [166]. However, subsequent studies notoriously reported 
findings of telomere shortening in obese children. Al-Attas and collaborators presented an inverse 
correlation between obesity and telomere length in boys, but not girls [167]. A subsequent, large 
case-control study (n=793) identified a 25% reduction in telomere length in obese children when 
compared to non-obese healthy controls [168]. Interestingly, Zhu and colleagues did not find an 
association between adiposity and telomere length in 667 adolescents aged between 14 and 18 years 
[169]. An extensive meta-analysis by Park and colleagues raised an interesting association between 
obesity in childhood and increased risk of morbidities and mortality in adulthood, independent of 
weight loss [170]. The associations between increased adiposity in childhood and telomere 
shortening are compelling, and further evidence is required to conclude upon the degree and 
consequences of telomere dysfunction in such obesity.  
It is of interest that increased markers of inflammation have been exhibited alongside telomere 
attrition in obese cancer patients [171]. A high BMI in individuals with obesity-associated 
polymorphisms correlated with increased levels of CRP and decreased telomere length [172]. 
Telomere shortening was also seen in conjunction with increased CRP and adiposity in a more recent 
investigation [173]. This research showed BMI, waist circumference, and body fat percentage to be 
inversely correlated with telomere length in adults. These findings strengthen the hypothesis for 
chronic, low-grade inflammation as a possible etiological route to DNA damage in obese subjects.  
7. Genetic Determinants of Obesity and DNA damage 
Genome wide association studies (GWAS) have indicated a number of single nucleotide 
polymorphisms (SNPs) to be associated with obesity. Of these, particular polymorphisms (such as 












risk of non-syndromic obesity [174]. Such genetic polymorphisms are likely to alter the activity of 
metabolic hormones, leading to reduced feelings of satiety and an increased caloric intake [175]. 
It has been investigated whether such genetic determinants can be responsible for the increasing 
evidence of DNA damage in obesity. A study evaluated the frequency of polymorphisms in genes 
coding for ghrelin (rs26802), ghrelin receptor (rs572169), leptin (rs7799039), leptin receptor 
(rs1137101) and FTO (rs9939609) in 300 morbidly obese Caucasian women alongside 300 controls 
[176]. These individuals were also investigated for oxidative DNA damage via the comet assay. 
Obesity was associated with a significantly increased frequency of the AA-FTO genotype allele A, 
decreased frequency of the TT-FTO genotype, and elevated DNA strand breaks. However, the 
degree of DNA damage was independent of genotype, indicating that these particular polymorphisms 
may not play an etiological role in the development of DNA damage in obese subjects, and suggests 
the damage may be caused by other pathological states such as low grade inflammation and 
oxidative stress. However, variants of the FTO have also been associated with an increased risk of 
breast cancer in African American [177] but not Caucasian women [178]. This suggests SNP 
associations and their consequences in obesity display strong ethnic variations. 
A population-based study discovered variants in the DNA repair genes MGMT (rs12917), MSH2 
(rs3732182 and rs4583514), MSH3 (rs1650663), XPG (rs17655), and XRCC1 (rs25487) that code for 
BER, NER and MMR pathways to elevate the risk of postmenopausal breast cancer in obese women 
[179]. Simultaneously, the research found obese women to be at increased risk of oxidative stress if 
they possess a polymorphism in the MPO gene. Similar findings were outlined in a meta-analysis 
that concluded polymorphisms of GPX1 and GPX7 genes that are associated with higher body fat 
and insulin resistance, contribute to oxidative stress in obesity, by lowering anti-oxidant defence 
[180]. Therefore, there is a possibility that certain genetic variants that predispose to obesity also 
promote pathogenesis of oxidative stress and DNA damage. If this pathological process is coupled 












Since genetic determinants of TL in adults do not correspond with TL in children, and genetic 
determinants of TL remain unconfirmed [181], there is a likelihood that telomere length shortening 
in children may be associated with obesity related ROS rather than genetic make-up. However, there 
is a greater need for further studies to identify the relationship between telomere length in obesity 
and the long-term risk of pathological conditions.  
8. Weight loss interventions and DNA Damage 
Decreasing adiposity to a certain degree may improve oxidative stress and DNA health in obesity. 
Bariatric surgery is an established method of weight-loss which has shown positive implications on 
obesity associated complications, including cardiovascular disease [182], obstructive sleep apnoea 
[183], non-alcoholic fatty liver disease [184] and a rapid improvement in type 2 diabetes [185].  
Bariatric surgery has also been suggested to reduce the risk of cancer by restoring genome stability 
and integrity [186–188]. Laparoscopic gastric band application has shown a reversal in oxidative 
DNA damage, as reduced levels of urinary 8-OHdG were identified 6 months after this surgical 
procedure in a group of morbidly obese patients [189]. The same surgical procedure has 
demonstrated a reduction in DNA double strand breaks with decreased levels of y-H2AX positive 
cells up to 7 years after surgery [190] and restoration of telomere length in obese men [191]. 
However, a study conducted on 107 obese subjects with and without metabolic syndrome reported 
no extension in telomere length after a 12 month follow up of bariatric surgery [192]. Although more 
recently, Bankoglu and colleagues reported a reduction in DNA breaks assessed by the comet assay 
in 56 blood samples 12 months after surgery [193]. Therefore, bariatric surgery appears to be 
propitious for improving DNA integrity and stability in obese adults. Whether such is the case in 
severe adolescent obesity could be explored.   
Dietary and lifestyle modifications have also been associated with a reduction of DNA damage in 
obesity. Following a two month intervention programme, governed by improvements in diet and 












modifications and consequent weight loss also reduced DNA damage in obese women with PCOS 
[195]. From these studies it can be deduced that DNA damage in obesity may be a reversible 
phenomenon. Although, it is also possible that gene mutations that have been induced and 
accumulated during the phase of obesity may persist beyond weight-loss.  
9. Conclusion 
Oxidative stress in obesity poses a significant threat to DNA stability and integrity as indicated by 
the growing number of investigations reporting a positive correlation between markers of oxidative 
DNA damage and increased adiposity. These associations raise concerns that the obese state may 
manifest with accelerated genome ageing and promote carcinogenesis.  Monitoring of acquired DNA 
damage may become an important part of clinical investigations in the management of obesity, 
alongside markers of inflammation and micro nutritional deficiencies in order to detect pre-
pathological changes. Potential benefits of monitoring ‘genome health’ in obesity include early 
detection of pre-cancerous alterations to establish urgency of personalised intervention measures and 
assess their progress. These avenues should be explored as DNA damage in obesity appears to be a 
reversible phenomenon. 
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Table 1. Associations between micronuclei (MNi) frequency and site-specific cancers.  
Cancer Site Study 
Population 
Cell type USED 
for Micronuclei 
(MNi) test 
Key Findings  Authors, 
Date 
Bladder 158 patients/ 
158 controls 
(age matched) 
PBLs Increase in MN frequency 
associated with increased risk 
of cancer  
Pardini et al., 
2017 [196] 
Breast 91 patients/ 
96 controls 
PBLs Higher frequency of MNi in 
breast cancer patients  
Varga et al., 
2006 [197] 
45 patients/  85 
controls (age 
matched)  
PBLs Higher frequency of MNi in 
breast cancer patients 




PBLs No significant difference of 
MNi frequency between 




Follow up of 
1650 adults 
PBLs Higher frequency of MNi at 
baseline in cancer patients. 
Murgia et al., 
2008 [78] 
Colorectal 25 cancer 
patients/ 26 
polyp patients/ 
31 controls  
PBLs 2.1x higher frequency of MNi 
in cancer patients than 
controls. Polyp patients had 
1.5x higher frequency of MNi 
than controls.  
Maffei et al., 
2014 [200] 
Encephalon Follow up of 
1650 adults 
PBLs Higher frequency of MNi at 
baseline in cancer patients. 




59 patients/ 59 
controls 
Cervical squamous 
epithelial cells  
20% higher frequency of MNi 
in patients. 
 




patients/ 20  
cancer patients/ 
20 controls 
PBLs 2.9x higher frequency of MNi 
in women with endometrial 
cancer. 
Kiraz et al., 
2016 [202] 





PBLs Higher MNi frequency in lung 

















Lymphoma Follow up of 
1650 adults 
PBLs Higher frequency of MNi at 
baseline in cancer patients. 
Murgia et al., 
2008 [78] 
Oral Follow up of 
1650 adults 
PBLs Higher frequency of MNi at 
baseline in cancer patients. 
Murgia et al., 
2008 [78] 
Pancreatic  346 patients/ 
449 controls 
PBLs 1.6x higher MNi frequency in 
pancreatic cancer patients. 
Chang, Li 
and Li, 2011 
[204] 
Stomach 6718 adult 
participants 
across 20 sites  
PBLs Higher frequencies of MNi 
were associated with 





Urogenital 6718 adult 
participants 
across 20 sites 
PBLs Higher frequencies of MNi 
were associated with 







Table 2. Associations between micronuclei (MNi) frequency and adiposity 
Date Study 
type  
Study population Cell type for 
MNi test 






PBLs Higher frequency of MNi in 
PCOS patients. 
Positive correlation between 
BMI and MNi frequency. 










PBLs Higher frequency of MNi in 
overweight PCOS patients. 
Insulin resistance was positively 
associated with aneuploidy of X 
chromosomes.  







PBLs Higher frequency of MNi in 






60 obese/ 20 
overweight/ 38  
children controls 
PBLs Higher frequency of MNi and y-
H2AX foci in overweight and 
obese children.  



















PBLs BMI not WHR is positively 
correlated with MNi frequency 
in all subjects.  
Donmez-








Erythrocytes Body mass is positively 
correlated with MNi frequency. 












No difference in MNi frequency 
between DIO and non-DIO 
mice. Erythrocytes showed an 







women and their 
fetal offspring  
PBLs Positive correlation of birth 
weight and length with MNi 
frequency, nucleoplasmic 
bridges and nuclear buds.  




300 Korean men 
and women aged 
30-59 years 
PBLs Positive correlation between age 
and MNi but not BMI.   
Cho et al [89] 
 
 
Table 3. Associations between 8-OHdG concentration and site-specific cancers.  
Cancer Site Study 
Population 
Tissue type for 8-
OHdG test 
Key Findings  Authors, 
Date 
Buccal mucosa 30 patients/  
30 controls 
Urine 8-OHdG higher in cancer 
patients. 
Murugaiyan 
et al., 2015 
[207] 
Breast 49 patients/  
49 controls 
Serum 8-OHdG higher in cancer 
patients. 
Himmetoglu 
et al., 2009 
[209] 
 
60 patients/ 60 
controls 
Urine 8-OHdG higher in cancer 
patients. 
Kuo et al., 
2007 [208] 
Colo-rectum 36 patients/ 40 
controls 
Serum 8-OHdG higher in cancer 
patients. 
Chang et al., 
2008 [210] 
84 patients/ 142 
controls 
Urine 8-OHdG higher in cancer 
patients. 













Oeosophagus  18 patients/ 12 
controls 
Serum 8-OHdG higher in cancer 
patients. 
Diakowska 
et al., 2007 
[212] 
Ovaries  84 patients  Serum and tumour 
tissue 
High 8-OHdG levels 
(>140pg/ml) are associated 
with poorer prognosis.  
Pylvas et al., 
2011 [213] 
Prostate 82 patients/ 82 
controls  






Table 4. Associations between 8-OHdG concentration and adiposity 
Date Study type  Study population Tissue type for 8-
ohdG test 
Key findings Authors 
2006 Case control 27 non-obese hernia 
patients 
Skeletal Muscle Weight gain was associated 
with increased 8-OHdG.  
De la Maza et 
al., [107] 
2006 Correlation 99 young adults  PBLs No correlation between BMI 




2007 Longitudinal  174 healthy adults Urine A decrease in BMI by 1.0 was 
associated with a 2.7% 
increase in 8-OHdG.  
Mizoue et al.,  
[109] 
2011 Correlation 103 adolescents  Serum BMI was positively correlated 
with 8-OHdG. 
 El Wakkad et 
al., [111] 
2014 Case control 83 obese/ 
21 overweight/ 21 
control adults 
Plasma 8-OHdG concentration was 
lower in the obese group. 
Donmez-
Altuntas et al., 
[86] 
2014 Correlation 159 healthy children Urine BMI was inversely correlated 
8-OHdG. 
Protano et al., 
[112] 
2015 Case control 24 obese/28 control 
children 


























Cancer Site Study 
Population 
Tissue/Cell type 
for -H2AX test 
Key Findings  Authors, Date 
Breast 31 patients and 
89 control 
Breast -H2AX higher in cancer 
patients. 
Zhou et al., 2013 
[120] 
Bladder 94 patients and 
8 controls 
Bladder  -H2AX higher in cancer 
patients. 
Bartkova et al., 
2005 [121] 
GI tract 320 normal and 
320 controls 
Lymphocytes -H2AX higher in colorectal 
cancer patients. 




Colorectal  -H2AX associated with poor 
cancer prognosis. 






-H2AX higher in cancerous 
epithelial tissue. 
Kim et al., 2010 
[217] 
Ovaries 87 patients and 
20 controls 
Epithelial ovarian -H2AX higher in cancer 
patients. 
Mei et al., 2015 
[122] 
Skin 9 benign and 
108 cancer 
tissues 
Melanocytes -H2AX higher in cancer 
tissue. 
Wasco et al., 2008 
[218] 
Thyroid 30 benign and 
153 cancer 
tissues 
Thyroid -H2AX higher in cancer 
tissue. 
Hu et al., 2015 
[219] 
 
Table 6. Associations between -H2AX frequency and adiposity 
Date Study 
type  
Study population Tissue/Cell type for 
-H2AX test 
Key findings Authors 
2010 Correlati
on 





Endothelial cells from visceral 
adipose tissue had greater γ-
H2AX positive foci than 





61 obese/ 20 
overweight/ 38 control 
children 
 
PBLs Higher γ-H2AX positive foci in 





23 obese/ 15 control 
adolescents  
PBLs Higher γ-H2AX positive foci in 
obese cohort. 




Obese and healthy 
weight 3-4 weeks old 
Pancreas  
Lung  
Higher γ-H2AX-positive foci in 
obese 9 to 13-week-old obese 


















rats. No differences in the 3-4 
week cohorts.  
 
Table 7. Associations between comet tails and and site-specific cancers 
Cancer Site Study 
Population 
Cell type for 
comet assay 
Key Findings  Authors, Date 
Breast 70 patients and 
70 controls 
PBLs Comet tails were significantly 
higher in cancer patients.  
Smith et al., 2003 
[142] 
35 patients, 15 
first degree 
relatives and 15 
controls 
PBLs Comet tails were significantly 
higher in cancer patients and 
first degree relatives. 
Kattimuthu et al., 
2012 [220] 
Bladder 114 patients and 
145 controls 
PBLs Comet tails were significantly 
higher in cancer patients. 
Schabath et al., 
2003 [221] 
Buccal Mucosa 54 patients and 
52 controls 
PBLs Comet tails were significantly 
higher in cancer patients. 
Katarkar et al., 2014 
[134] 
55 patients and 
55 controls 
PBLs Comet tails were significantly 
higher in cancer patients. 
Rawat et al., 2018 
[222] 
Uterus 106 patients and 
30 controls 
PBLs Comet tails were significantly 
higher in cancer patients. 




Table 8. Associations between comet tails and adiposity  
Date Study type  Study population Cell type for 
comet assay 
Key findings Authors 
2003 Case control 70 breast cancer 
patients/ 70 
controls 
PBLs BMI was positively correlated 
with comet tails in cancer 
patients but inversely 
correlated in controls.   
Smith et al., [142] 
2006 Correlation 99 females (aged 
19-31) 
PBLs BMI was positively correlated 
with comet tails. 
Hofer et al., [108] 
2010 Case control 20 pregnant 
women/  
10 controls 
Leukocytes  BMI was positively correlated 
with comet tails in pregnant 
women. 
Bukhari et al., [137] 
2011 Case control 20 obese/ 
20 normal weight 
PBLs Higher frequency of comet 
tails in obese and ‘normal-













+ fat mass > 30%/ 
20 control 
females 
weight obese’ cohorts.  
2012 Case Control 36 obese/15 
control adults  
Leukocytes  Higher frequency of comet 
tails in obese cohort. 
Gandhi and Kaur 
[138] 
2013 Case Control  Lean and obese 
Zucker rats at 3, 
6, and 15 months 
old assigned to a 
sleep-deprived 
group or home-
cage control (n=5 
in each group) 
PBLs Higher frequency of comet 
tails in obese rats at 15 months 
old, irrespective of sleep 
status.  





50 adults PBLs Calorie restriction was 
associated with weight-loss 
and a decrease in comet tails. 




Table 9. Associations between telomere length (TL) and site-specific cancers.  




Key Findings  Authors, 
Date 
Bladder 63 patients/  
158 controls  
Buccal cells via 
qPCR 





Breast 287 patients/  
350 sister controls 
PBLs via qPCR 
 
No significant difference in 
TL between groups.  
Shen et al., 
2007 [224] 
601 patients/  
695 controls 
PBLs via qPCR 
 
Shorter TL in cancer 
patients. 
Qu et al., 
2013 [155] 
 
GI tract 396 patients/  
378 controls 
PBLs via qPCR Shorter TL in cancer 
patients.   
Liu et al., 
2009 [225] 
Lung 243 patients/  
243 controls 
PBLs via qPCR Shorter TL in cancer 
patients. 













215 patients/ 215 
controls 
PBLs via qPCR Shorter TL in cancer 
patients. 
Lan et al., 
2013 [159] 










Pancreas 499 patients/  
963 controls 
PBLs via qPCR Shorter telomeres and 
extremely long telomeres 
both related to increased 










of prostate cells 
Cells with high-grade 
prostatic intraepithelial 
neoplasia had shorter 
telomeres than normal cells 









cases/ 870 controls 
PBLs via qPCR Short TL was associated 
with a decreased number of 
moles and decreased risk of 
melanoma and BCC.  





Table 10. Associations between telomere length (TL) and adiposity  
Date Study type  Study population Cell type & technique for 
telomere length test 
Key findings Authors 
2005 Case control 119 obese/ 85 
healthy weight 
female twins 
PBLs via TRF TRF length was lowest in 
the obese cohort and 
correlated with BMI and 
serum leptin.  
Valdes et al., 
[161] 
2008 Correlation 989 adults Leucocytes via qPCR Inverse correlation between 
BMI and TL in women.  
Nordfjäll et 
al., [162] 
2008 Case control 53 children/ 
23 adults  
PBLs via TRF No difference in TL in  
children. Obese adults had 
shorter TL.  




647 female adults  Leucocytes via qPCR High BMI and hip 
circumference inversely 
correlated with TL. Obese 













females had shortest TL.   
2010 Case control 51 obese/  
21 non-obese adults  
Subcutaneous adipose 
tissue via Southern 
blotting 
BMI inversely correlated 
with TL. Formerly obese 





2010 Correlation 317 adults 
(aged 40-64 years) 
Leukocytes via qPCR No significant correlations 
between BMI or visceral 
adipose tissue and TL.  
Diaz et al., 
[165] 
2010 Correlation 2284 females Leukocytes via qPCR Waist circumference was 
inversely correlated with 
TL.  
Cassidy et al., 
[229] 
2011 Correlation 309 non-Hispanic 
white participants 
aged 8 to 80 years  
Leukocytes via qPCR BMI, waist circumference, 
hip circumference, total 
body fat, and visceral 
adipose tissue volume 
inversely correlated with 
TL.   
Lee et al., 
[230] 
2011 Case control 793 children (aged 
2-17 years) 
Leukocytes via qPCR 23.9% shorter TL in obese 
children.   








Leukocytes via qPCR BF% and subcutaneous fat 
inversely correlated with 
TL.  No correlation between 
BMI and TL. 7 year follow 
up showed inverse 
correlation with BMI and 
BF%.   
Njajou et al., 
[231] 
 
2013 Correlation 2,912 females (aged 
40-70 years) 
Leukocytes via qPCR TL inversely correlated with 
BMI, waist circumference, 
waist-to-height ratio, weight, 
and hip circumference but 
not waist to hip ratio.  
Cui et al., 
[232] 
2016 Correlation 7527 adults  
(aged 20-84) 
Leukocytes via qPCR Telomere length inversely 
correlated with BMI, waist 
circumference, BF% and C-
reactive protein.  
Rehkopf et al., 
[173] 
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